Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients
Crossref DOI link: https://doi.org/10.1007/s10067-017-3952-7
Published Online: 2018-01-04
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hachiya, Akira
Kobayashi, Norimoto
Matsuzaki, Satoshi
Takeuchi, Yusuke
Akazawa, Yohei
Shigemura, Tomonari
Motoki, Noriko
Masumoto, Junya
Agematsu, Kazunaga
License valid from 2018-01-04